DARE insider filings

Dare Bioscience, Inc. — 36 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-07-02. Screen DARE transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for DARE between 2026-07-10 and 2026-10-08. The table below lists the most recent filings on record.

Recent insider filings — Dare Bioscience, Inc.

FiledFormInsiderReported transactionsSource
2026-07-024Grossman Jessica D. — DirectorGrant/award (A): 26,066 @ $0EDGAR
2026-07-024Kelley Susan L. — DirectorGrant/award (A): 23,696 @ $0EDGAR
2026-07-024Matz Gregory W — DirectorGrant/award (A): 30,805 @ $0EDGAR
2026-07-024Steele Robin Joan — DirectorGrant/award (A): 26,540 @ $0EDGAR
2026-07-024RASTETTER WILLIAM H — DirectorGrant/award (A): 38,862 @ $0EDGAR
2026-06-114Grossman Jessica D. — DirectorGrant/award (A): 10,000 (derivative) @ $0EDGAR
2026-06-114Matz Gregory W — DirectorGrant/award (A): 10,000 (derivative) @ $0EDGAR
2026-06-114Kelley Susan L. — DirectorGrant/award (A): 10,000 (derivative) @ $0EDGAR
2026-06-114Steele Robin Joan — DirectorGrant/award (A): 10,000 (derivative) @ $0EDGAR
2026-06-114RASTETTER WILLIAM H — DirectorGrant/award (A): 10,000 (derivative) @ $0EDGAR
2026-02-204JOHNSON SABRINA MARTUCCI — Chef Executive Officer, DirectorGrant/award (A): 10,800 (derivative) · Grant/award (A): 21,600 (derivative)EDGAR
2026-02-024Haring-Layton MarDee — Chief Accounting OfficerGrant/award (A): 49,000 (derivative) @ $0EDGAR
2026-02-024JOHNSON SABRINA MARTUCCI — Chef Executive Officer, DirectorGrant/award (A): 172,000 (derivative) @ $0EDGAR
2025-09-044Haring-Layton MarDee — Chief Accounting OfficerGrant/award (A): 57,000 (derivative) @ $0EDGAR
2025-07-104Matz Gregory W — DirectorGrant/award (A): 4,500 (derivative) @ $0EDGAR
2025-07-104Grossman Jessica D. — DirectorGrant/award (A): 4,500 (derivative) @ $0EDGAR
2025-07-104Kelley Susan L. — DirectorGrant/award (A): 4,500 (derivative) @ $0EDGAR
2025-07-104Steele Robin Joan — DirectorGrant/award (A): 4,500 (derivative) @ $0EDGAR
2025-07-104RASTETTER WILLIAM H — DirectorGrant/award (A): 4,500 (derivative) @ $0EDGAR
2025-01-314Haring-Layton MarDee — Chief Accounting OfficerGrant/award (A): 38,000 (derivative) @ $0EDGAR
2025-01-314JOHNSON SABRINA MARTUCCI — Chef Executive Officer, DirectorGrant/award (A): 107,000 (derivative) @ $0EDGAR
2024-06-074Grossman Jessica D. — DirectorGrant/award (A): 40,000 (derivative) @ $0EDGAR
2024-06-074Kelley Susan L. — DirectorGrant/award (A): 40,000 (derivative) @ $0EDGAR
2024-06-074Matz Gregory W — DirectorGrant/award (A): 40,000 (derivative) @ $0EDGAR
2024-06-074Steele Robin Joan — DirectorGrant/award (A): 40,000 (derivative) @ $0EDGAR
2024-06-074RASTETTER WILLIAM H — DirectorGrant/award (A): 40,000 (derivative) @ $0EDGAR
2024-03-144Fair John A — Chief Commercial OfficerGrant/award (A): 290,000 (derivative) @ $0EDGAR
2024-03-144Haring-Layton MarDee — Chief Accounting OfficerGrant/award (A): 290,000 (derivative) @ $0EDGAR
2024-03-144JOHNSON SABRINA MARTUCCI — Chef Executive Officer, DirectorGrant/award (A): 750,000 (derivative) @ $0EDGAR
2023-06-214Grossman Jessica D. — DirectorGrant/award (A): 40,000 (derivative) @ $0EDGAR
2023-06-214Ononye-Onyia Sophia Nnenna — DirectorGrant/award (A): 40,000 (derivative) @ $0EDGAR
2023-06-214Kelley Susan L. — DirectorGrant/award (A): 40,000 (derivative) @ $0EDGAR
2023-06-214Matz Gregory W — DirectorGrant/award (A): 40,000 (derivative) @ $0EDGAR
2023-06-214Blanchard Cheryl R — DirectorGrant/award (A): 40,000 (derivative) @ $0EDGAR
2023-06-214Steele Robin Joan — DirectorGrant/award (A): 40,000 (derivative) @ $0EDGAR
2023-06-214RASTETTER WILLIAM H — DirectorGrant/award (A): 40,000 (derivative) @ $0EDGAR

Recent 8-K events — Dare Bioscience, Inc.

FiledFormItems reportedSource
2026-10-028-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of ListingEDGAR
2026-10-018-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-09-118-K5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal YearEDGAR
2026-09-098-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-08-178-K1.01 — Entry into a Material Definitive Agreement
3.02 — Unregistered Sales of Equity Securities
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-08-138-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-07-248-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-07-178-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of ListingEDGAR
2026-07-138-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-06-228-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR

Registration filings — Dare Bioscience, Inc.

Securities Act registration lifecycles tracked for this issuer (live-forward since 2026-08-01), threaded by SEC file number.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=DARE returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →